Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heparin: what is it? How does it work?

B S Schwartz1

  • 1Department of Medicine, University of Wisconsin, Madison.

Clinical Cardiology
|April 1, 1990
PubMed
Summary
This summary is machine-generated.

Heparin, an anticoagulant, prevents blood clots by binding to antithrombin III. Adjusting dosage or using low-molecular-weight heparins can mitigate bleeding risks associated with this important medication.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of community types and features in a case-control analysis of new onset type 2 diabetes across a diverse geography in Pennsylvania.

BMJ open·2021
Same author

Longitudinal evaluation of clustering of chronic sinonasal and related symptoms using exploratory factor analysis.

Allergy·2018
Same author

Prevalence, severity, and risk factors for acute exacerbations of nasal and sinus symptoms by chronic rhinosinusitis status.

Allergy·2018
Same author

Nasal and sinus symptoms and chronic rhinosinusitis in a population-based sample.

Allergy·2016
Same author

Early-life antibiotic use and subsequent diagnosis of food allergy and allergic diseases.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2016
Same author

Antibiotic use and childhood body mass index trajectory.

International journal of obesity (2005)·2015
Same journal

In-Hospital Cardiac Arrest Detection Performance Analysis and Comparison on Effective Feature Selection.

Clinical cardiology·2026
Same journal

Interpreting the Association Between Diuretic Intensity Score and Mortality: The Potential Roles of Diuretic Responsiveness and Mineralocorticoid Receptor Antagonist Therapy.

Clinical cardiology·2026
Same journal

Heart Failure With Preserved Ejection Fraction-Like Phenotype in Coronary Artery Disease and Obstructive Sleep Apnea: Insights From the RICCADSA Cohort.

Clinical cardiology·2026
Same journal

Ethanol Infusion Into the Vein of Marshall for Atrial Fibrillation: Clinical Efficacy and Technical Limitations.

Clinical cardiology·2026
Same journal

Methodological Considerations Regarding Diuretic Intensity Score and Mortality in Hospitalized Heart Failure Patients.

Clinical cardiology·2026
Same journal

Inpatient Outcomes and Complications After Left Atrial Appendage Occlusion in Rural Versus Urban Hospitals in the United States.

Clinical cardiology·2026
See all related articles

Area of Science:

  • Biochemistry
  • Pharmacology
  • Hematology

Background:

  • Heparin is a crucial anticoagulant agent that prevents thrombosis.
  • Its mechanism involves interaction with antithrombin III.
  • Heparin's precursor molecule comprises mucopolysaccharides, amino acids, and sugars.

Purpose of the Study:

  • To elucidate the chemical composition and functional domains of heparin.
  • To understand the mechanisms underlying heparin's anticoagulant activity.
  • To identify factors contributing to bleeding complications and potential mitigation strategies.

Main Methods:

  • Analysis of heparin precursor molecule composition.
  • Definition of functional domains through interaction studies with antithrombin III.

Related Experiment Videos

  • Investigation of heparin's interaction with platelets.

    • Main Results:

    • Heparin's structure includes mucopolysaccharides, amino acids, and sugars.
    • Three distinct functional domains of heparin activity have been identified.
    • Heparin's interaction with platelets can lead to bleeding complications.

    Conclusions:

    • Heparin effectively inhibits thrombosis via antithrombin III.
    • Understanding heparin's structure and domains is key to its function.
    • Therapeutic strategies like low-molecular-weight heparins and dosage adjustments can manage bleeding risks.